C. Piazza

C. Piazza

Director Ejecutivo en
IGL Pharma, Inc.
.
79 años
Health Technology
Consumer Services
Commercial Services

Perfil

C.
Richard Piazza
was the founder of QSAM Biosciences, Inc. (founded in 2004) where he served as the Executive Chairman from 2020 to 2024.
He is currently the President & Chief Executive Officer of IGL Pharma, Inc. (since 2017) and the Chairman of NovaScan, Inc. (since 2018).
In the past, he held positions as the President & Chief Executive Officer of Maxia Pharmaceuticals, Inc. (2001-2002), VitaGen, Inc. (2002-2003), and TheraFuse, Inc. (2003-2004).
He also served as the Chief Executive Officer of SynVivo, Inc. (2014-2016) and as the Managing Director of Healthios Capital Markets LLC (2004-2007) and the Managing Partner of La Jolla Capital Partners, Inc. (2004-2007).
Additionally, he has held the title of Chairman at Chemokine Therapeutics Corp.
Dr. Piazza obtained a doctorate degree from the University of Leeds, a graduate degree from the State University of New York at Buffalo, and an undergraduate degree from The State University of New York.

Cargos activos de C. Piazza

EmpresasCargoInicio
Director Ejecutivo 01/01/2017
Presidente 01/11/2018

Antiguos cargos conocidos de C. Piazza.

EmpresasCargoFin
Fundador 02/05/2024
Director Ejecutivo 01/01/2016
La Jolla Capital Partners, Inc.
Corporate Officer/Principal 01/01/2007
Corporate Officer/Principal 01/01/2007
Presidente 01/09/2004
Ver el detalle de la experiencia de C. Piazza.

Formación de C. Piazza.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

25

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Finance

La Jolla Capital Partners, Inc.

Health Technology

Process Industries

Health Services

Health Technology

Technology Services